Nureca Ltd

₹ 235 0.08%

07 Oct - close price

About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.^[1]

Key Points

Business Overview:^[1]^[2]
NL is a digitally first, consumer healthcare company with presence in categories such
as home diagnostics, wellness devices, and personal fitness equipment under brands like
Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26

Website BSE NSE

Market Cap ₹ 235 Cr.
Current Price ₹ 235
High / Low ₹ 448 / 198
Stock P/E
Book Value ₹ 194
Dividend Yield 0.00 %
ROCE -0.90 %
ROE -1.12 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company is expected to give good quarter

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of 1.98% over past five years.
Company has a low return on equity of -3.23% over last 3 years.
Earnings include an other income of Rs.9.21 Cr.
Company's cost of borrowing seems high
Promoter holding has decreased over last 3 years: -5.67%
Working capital days have increased from 255 days to 434 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	25.53	36.78	27.79	21.23	21.23	31.35	22.37	16.97	20.27	31.19	26.46	31.74	34.18
	31.25	41.69	28.71	24.69	24.13	29.97	26.62	21.40	22.63	33.54	30.47	30.54	34.74
Operating Profit	-5.72	-4.91	-0.92	-3.46	-2.90	1.38	-4.25	-4.43	-2.36	-2.35	-4.01	1.20	-0.56
OPM %	-22.41%	-13.35%	-3.31%	-16.30%	-13.66%	4.40%	-19.00%	-26.10%	-11.64%	-7.53%	-15.15%	3.78%	-1.64%
	1.17	1.89	1.90	2.15	2.67	3.20	5.90	-1.26	5.79	3.17	1.48	1.99	2.57
Interest	0.14	0.10	0.11	0.10	0.12	0.08	0.11	0.18	0.15	0.27	0.18	0.62	0.25
Depreciation	0.61	0.62	0.60	0.56	0.58	0.59	0.59	0.60	0.66	0.62	0.54	0.52	0.53
Profit before tax	-5.30	-3.74	0.27	-1.97	-0.93	3.91	0.95	-6.47	2.62	-0.07	-3.25	2.05	1.23
Tax %	-22.08%	-22.73%	-11.11%	-22.34%	-23.66%	25.83%	82.11%	-35.86%	36.64%	585.71%	-13.85%	-20.00%	34.15%
	-4.13	-2.89	0.30	-1.53	-0.71	2.89	0.17	-4.15	1.66	-0.48	-2.80	2.47	0.81
EPS in Rs	-4.13	-2.89	0.30	-1.53	-0.71	2.89	0.17	-4.15	1.66	-0.48	-2.80	2.47	0.81
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	62	99	213	256	111	92	110	124
	53	90	152	200	126	102	117	129
Operating Profit	9	10	62	56	-15	-10	-8	-6
OPM %	15%	10%	29%	22%	-13%	-11%	-7%	-5%
	0	0	3	8	7	11	12	9
Interest	0	1	2	1	0	0	1	1
Depreciation	0	0	0	1	2	2	2	2
Profit before tax	9	9	62	61	-11	-3	1	-0
Tax %	30%	26%	26%	26%	-23%	-30%	37%
	6	6	46	45	-8	-2	1	0
EPS in Rs	6,230.00	6,400.00	46.37	44.96	-8.25	-1.79	0.85	0.00
Dividend Payout %	0%	0%	4%	7%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	2%
3 Years:	-25%
TTM:	36%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-100%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-36%
1 Year:	-27%

Return on Equity
10 Years:	%
5 Years:	8%
3 Years:	-3%
Last Year:	-1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.01	0.01	10	10	10	10	10
Reserves	8	15	153	193	185	183	184
	0	10	4	4	3	3	5
	15	9	19	12	8	10	11
Total Liabilities	24	34	186	219	207	205	210
	1	1	4	10	9	7	9
CWIP	0	0	0	0	0	0	0
Investments	0	0	0	33	59	94	1
	23	33	182	175	139	104	200
Total Assets	24	34	186	219	207	205	210

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	0	-8	35	1	10	-3	-19
	-0	-0	-110	-3	-16	18	8
	-0	8	92	-7	-2	-1	-0
Net Cash Flow	0	-0	17	-9	-8	14	-11

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	52	47	0	4	14	6	11
Inventory Days	123	93	135	174	167	186	214
Days Payable	89	33	32	13	24	31	35
Cash Conversion Cycle	87	107	103	165	157	161	190
Working Capital Days	45	85	61	109	156	176	434
ROCE %		57%	67%	33%	-6%	-4%	-1%

Shareholding Pattern

Numbers in percentages

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	70.00%	62.98%	62.98%	62.98%	63.24%	63.24%	63.24%	63.24%	63.78%	64.06%	64.30%	64.33%
	1.67%	0.10%	0.10%	0.10%	0.10%	0.07%	0.07%	0.07%	0.69%	0.36%	1.07%	0.07%
	0.55%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%
	27.78%	36.92%	36.91%	36.92%	36.67%	36.69%	36.69%	36.69%	35.53%	35.54%	34.59%	35.56%
No. of Shareholders	63,911	62,007	58,560	55,569	52,255	49,600	45,996	43,813	41,986	41,314	39,304	38,075

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Jun 2025
	70.00%	70.00%	62.98%	63.24%	64.30%	64.33%
	10.51%	12.22%	0.10%	0.07%	1.07%	0.07%
	8.09%	5.23%	0.00%	0.00%	0.04%	0.04%
	11.40%	12.55%	36.91%	36.69%	34.59%	35.56%
No. of Shareholders	7,827	26,123	58,560	45,996	39,304	38,075

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jul 2025

Transcript

Notes
PPT
May 2025

Transcript

Notes
PPT
Jan 2025

Transcript

Notes
PPT
Oct 2024

Transcript

Notes
PPT
Aug 2024

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Nov 2023

Transcript

Notes
PPT
Aug 2023

Transcript

Notes
PPT